The global Pompe Disease market size reached USD 1,386.09 Million in 2021 and is expected to register a revenue CAGR of 3.9% during the forecast period. Increasing prevalence of Pompe Disease, rising number of clinical studies and trials in the field of Pompe-disease-based treatments, and introduction of novel and advanced screening platforms for early diagnosis are crucial factors driving market revenue growth.
Pompe disease is a hereditary, frequently fatal ailment that affects the heart and skeletal muscles. It is thought to affect one in every 40,000 births, according to the National Institute of Neurological Disorders and Stroke. Mutations in a gene that produces an enzyme called acid alpha-glucosidase cause it (GAA). Many researchers are trying to better understand the earliest features and manifestations of late-onset Pompe disease novel screening platforms such as newborn screening.
Get a sample of the report @ https://www.emergenresearch.com/request-sample/1081
According to the Muscular Dystrophy Association (MDA), 20 states are now testit newborns through newborn screening platforms for Pompe Disease, the latest neuromuscular disease, which is being added to a list of significant genetic disorders for which children can be tested shortly after delivery in the United States. We are investigating if starting people early on the right dose of ERT could impact outcomes. Targeted screening of at-risk individuals, as well as general newborn screening, can lead to early detection and treatment of Pompe disease patients, potentially improving clinical outcomes. Other advanced and creative diagnostic systems, such as enzyme activity assessment using a tandem-mass-spectrometry-based assay for Pompe disease, are being produced, examined, and validated in large screening programs.
Emergen Research has recently published a detailed report on the global Pompe Disease Market formulated through extensive primary and secondary research. The report offers in-depth knowledge and analysis of the Pompe Disease Market through verified and validated data curated to offer accurate insights. The report also offers a region wise and country wise analysis of the Pompe Disease Market and contains a detailed analysis of the key elements influencing the growth of the market in the region. The research study also contains historical, current, and forecast estimations for each sector, segment, sub-segment, and regions.
To know more about the report @ https://www.emergenresearch.com/industry-report/pompe-disease-market
Emergen Research has segmented global Pompe Disease market on the basis of type, treatment type, end-use and region:
Type Outlook (Revenue, USD Million; 2019-2030)
Infantile-Onset Pompe Disease (IOPD)
Late-Onset Pompe Disease (LOPD)
Treatment Type Outlook (Revenue, USD Million; 2019-2030)
Enzyme Replacement Therapy (ERT)
Chaperone Therapy
Substrate Replacement Therapy (SRT)
Others
End-Use Outlook (Revenue, USD Million; 2019-2030)
Hospitals
Diagnostic Centers
Others
The report further studies the key companies operating in the industry and their company profiles, product portfolio, expansion strategies, and strategic alliances such as mergers and acquisitions, collaborations, and joint ventures, among others. It also offers insights into their market reach and global position, along with highlights about their achievements and financial standings.
Key players include
Sanofi S.A.,
Amicus Therapeutics, Inc.,
BioMarin Pharmaceutical,
Valerion Therapeutics,
Oxyrane,
Genzyme Corporation,
EpiVax, Inc.,
Bayer AG,
Audentes Therapeutics, and
Sangamo Therapeutics
Request a discount on the report @ https://www.emergenresearch.com/request-discount/1081
Regional Segmentation
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The report addresses the following key points:
The report estimates the expected market size from 2022-2030
The report provides a forecast of market drivers, restraints, and future opportunities for the Pompe Disease market
The report further analyses the changing market dynamics
Regional analysis and segmentation of the market with analysis of the regions and segments expected to dominate the market growth
Extensive competitive landscape mapping with profiles of the key competitors
In-depth analysis of business strategies and collaborations such as mergers and acquisitions adopted by the key companies
Revenue forecast, country scope, application insights, and product insights
Request a customization of the report @ https://www.emergenresearch.com/request-for-customization/1081
Thank you for reading the research report. To get more information about the customized report and customization plan, kindly connect to us and we will provide you with the well-suited customized report.
Take a Look at our other Reports:
In-Situ Hybridization Market
Interventional Cardiology Devices Market
Laboratory Centrifuges Market
Nanotechnology Market
Near-Infrared Imaging Market
Orthopedic Biomaterial Market
RNA Transcriptomics Market
About Us:
At Emergen Research, we believe in advancing with technology. We are growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release @ https://www.emergenresearch.com/press-release/global-pompe-disease-market
